Belage2
Knowflake Posts: 271
From:
Registered: Jan 2025
|
posted April 17, 2025 02:17 PM
  
Today (4/10/2025), the U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods. The new approach is designed to improve drug safety and accelerate the evaluation process, while reducing animal experimentation, lowering research and development (R&D) costs, and ultimately, drug prices.The FDA’s animal testing requirement will be reduced, refined, or potentially replaced using a range of approaches, including AI-based computational models of toxicity and cell lines and organoid toxicity testing in a laboratory setting (so-called New Approach Methodologies or NAMs data). https://www.fda.gov/news-even ts/press-announcements/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs IP: Logged |
Lindaland
UBBFriend: Email This Page to Someone! 
posted April 17, 2025 03:44 PM